Fisher JL - Search Results

1

A role for GLUT3 in glioblastoma cell invasion that is not recapitulated by GLUT1.

Libby CJ, Gc S, Benavides GA, Fisher JL, Williford SE, Zhang S, Tran AN, Gordon ER, Jones AB, Tuy K, Flavahan W, Gordillo J, Long A, Cooper SJ, Lasseigne BN, Augelli-Szafran CE, Darley-Usmar V, Hjelmeland AB. Libby CJ, et al. Among authors: fisher jl. Cell Adh Migr. 2021 Dec;15(1):101-115. doi: 10.1080/19336918.2021.1903684. Cell Adh Migr. 2021. PMID: 33843470 Free PMC article.

2

Considerations and challenges for sex-aware drug repurposing.

Fisher JL, Jones EF, Flanary VL, Williams AS, Ramsey EJ, Lasseigne BN. Fisher JL, et al. Biol Sex Differ. 2022 Mar 25;13(1):13. doi: 10.1186/s13293-022-00420-8. Biol Sex Differ. 2022. PMID: 35337371 Free PMC article. Review.

3

Evaluating cancer cell line and patient-derived xenograft recapitulation of tumor and non-diseased tissue gene expression profiles in silico.

Williams AS, Wilk EJ, Fisher JL, Lasseigne BN. Williams AS, et al. Among authors: fisher jl. bioRxiv [Preprint]. 2023 Jun 15:2023.04.11.536431. doi: 10.1101/2023.04.11.536431. bioRxiv. 2023. PMID: 37090499 Free PMC article. Updated. Preprint.

4

CINmetrics: an R package for analyzing copy number aberrations as a measure of chromosomal instability.

Oza VH, Fisher JL, Darji R, Lasseigne BN. Oza VH, et al. Among authors: fisher jl. PeerJ. 2023 Apr 25;11:e15244. doi: 10.7717/peerj.15244. eCollection 2023. PeerJ. 2023. PMID: 37123011 Free PMC article.

5

Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion.

Wilk EJ, Howton TC, Fisher JL, Oza VH, Brownlee RT, McPherson KC, Cleary HL, Yoder BK, George JF, Mrug M, Lasseigne BN. Wilk EJ, et al. Among authors: fisher jl. Mol Med. 2023 May 22;29(1):67. doi: 10.1186/s10020-023-00664-z. Mol Med. 2023. PMID: 37217845 Free PMC article.

6

Inferring chromosomal instability from copy number aberrations as a measure of chromosomal instability across human cancers.

Taluri S, Oza VH, Soelter TM, Fisher JL, Lasseigne BN. Taluri S, et al. Among authors: fisher jl. bioRxiv [Preprint]. 2023 Aug 16:2023.05.24.542174. doi: 10.1101/2023.05.24.542174. bioRxiv. 2023. PMID: 37292608 Free PMC article. Updated. Preprint.

7

Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes.

Fisher JL, Clark AD, Jones EF, Lasseigne BN. Fisher JL, et al. bioRxiv [Preprint]. 2023 Nov 15:2023.05.23.541950. doi: 10.1101/2023.05.23.541950. bioRxiv. 2023. PMID: 37362157 Free PMC article. Updated. Preprint.

8

Evaluating cancer cell line and patient-derived xenograft recapitulation of tumor and non-diseased tissue gene expression profiles in silico.

Williams AS, Wilk EJ, Fisher JL, Lasseigne BN. Williams AS, et al. Among authors: fisher jl. Cancer Rep (Hoboken). 2023 Sep;6(9):e1874. doi: 10.1002/cnr2.1874. Epub 2023 Aug 2. Cancer Rep (Hoboken). 2023. PMID: 37533331 Free PMC article.

9

Inferring chromosomal instability from copy number aberrations as a measure of chromosomal instability across human cancers.

Taluri S, Oza VH, Soelter TM, Fisher JL, Lasseigne BN. Taluri S, et al. Among authors: fisher jl. Cancer Rep (Hoboken). 2023 Dec;6(12):e1902. doi: 10.1002/cnr2.1902. Epub 2023 Sep 8. Cancer Rep (Hoboken). 2023. PMID: 37680168 Free PMC article.

10

Computational Advancements in Cancer Combination Therapy Prediction.

Flanary VL, Fisher JL, Wilk EJ, Howton TC, Lasseigne BN. Flanary VL, et al. Among authors: fisher jl. JCO Precis Oncol. 2023 Sep;7:e2300261. doi: 10.1200/PO.23.00261. JCO Precis Oncol. 2023. PMID: 37824797

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

233 results

Search Page